Biocon Executive Chairperson on Insulin Capacity
Biocon and Biocon Biologics Executive Chairperson, Kiran Mazumdar-Shaw, says they're adding capacity at their insulin facility in Malaysia and sees a "windfall" from Novo Nordisk's global pullback from the production of the drug. She spoke exclusively on Bloomberg's "Insight with Haslinda Amin."
Terms and Privacy Policy